-
EP2018853
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2018853
| EP2018853 - Pharmaceutical compositions comprising a HMG COA reductase inhibitor [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 09.12.2016 Database last updated on 29.03.2025 | Most recent event Tooltip | 09.12.2016 | Application deemed to be withdrawn | published on 11.01.2017 [2017/02] | Applicant(s) | For all designated states AstraZeneca AB AstraZeneca Intellectual Property 151 85 Södertälje / SE | [2009/05] | Inventor(s) | 01 /
Creekmore, Joseph, Richard 1800 Concord Pike Wilmington, DE 19850-5437 / US | 02 /
Wiggins, Norman, Alfred 1800 Concord Pike Wilmington, DE 19850-5437 / US | [2009/05] | Application number, filing date | 08165575.5 | 04.08.2000 | [2009/05] | Priority number, date | GB20000001621 | 26.01.2000 Original published format: GB 0001621 | [2009/05] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2018853 | Date: | 28.01.2009 | Language: | EN | [2009/05] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 22.12.2008 | Classification | IPC: | A61K9/20, A61K31/505, A61K9/16, A61K9/26, A61K9/32 | [2009/05] | CPC: |
A61K9/2866 (EP,US);
A61K31/505 (EP,FI,KR,US);
A61K31/435 (EP,US);
A61K47/02 (FI);
A61K9/2009 (EP,US);
A61K9/2018 (EP,US);
A61K9/2027 (EP,US);
A61K9/2054 (EP,US);
A61K9/2813 (EP,FI,US);
A61K9/2826 (EP,US);
A61P19/00 (EP);
A61P3/00 (EP);
A61P3/06 (EP);
A61P3/08 (EP);
A61P43/00 (EP);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2009/05] | Extension states | AL | 28.07.2009 | LT | 28.07.2009 | LV | 28.07.2009 | MK | 28.07.2009 | RO | 28.07.2009 | SI | 28.07.2009 | Title | German: | Pharmazeutische Zusammensetzungen mit einem HMG-COA-Reduktase-Hemmer | [2009/05] | English: | Pharmaceutical compositions comprising a HMG COA reductase inhibitor | [2009/05] | French: | Compositions pharmaceutiques comportant un inhibiteur de réductase HMG COA | [2009/05] | Examination procedure | 01.10.2008 | Examination requested [2009/05] | 20.01.2009 | Despatch of a communication from the examining division (Time limit: M04) | 13.02.2009 | Reply to a communication from the examining division | 19.02.2009 | Observations by third parties | 24.07.2009 | Observations by third parties | 25.09.2009 | Date of oral proceedings | 26.10.2009 | Despatch of communication that the application is refused, reason: substantive examination {1} | 26.10.2009 | Minutes of oral proceedings despatched | 20.05.2015 | Communication of intention to grant the patent | 30.09.2015 | Fee for grant paid | 30.09.2015 | Fee for publishing/printing paid | 01.10.2015 | Application deemed to be withdrawn, date of legal effect [2017/02] | 09.11.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2017/02] | Appeal following examination | 18.12.2009 | Appeal received No. T0571/10 | 01.03.2010 | Statement of grounds filed | 03.06.2014 | Result of appeal procedure: remittal for grant | 03.06.2014 | Date of oral proceedings | 10.06.2014 | Minutes of oral proceedings despatched | Parent application(s) Tooltip | EP00951701.2 / EP1251831 | Divisional application(s) | EP09171015.2 / EP2133070 | EP10180659.4 / EP2266540 | EP14170807.3 / EP2774609 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20000951701) is 15.12.2005 | Fees paid | Renewal fee | 02.02.2009 | Renewal fee patent year 03 | 02.02.2009 | Renewal fee patent year 04 | 02.02.2009 | Renewal fee patent year 05 | 02.02.2009 | Renewal fee patent year 06 | 02.02.2009 | Renewal fee patent year 07 | 02.02.2009 | Renewal fee patent year 08 | 02.02.2009 | Renewal fee patent year 09 | 31.08.2009 | Renewal fee patent year 10 | 31.08.2010 | Renewal fee patent year 11 | 31.08.2011 | Renewal fee patent year 12 | 31.08.2012 | Renewal fee patent year 13 | 02.09.2013 | Renewal fee patent year 14 | 01.09.2014 | Renewal fee patent year 15 | 31.08.2015 | Renewal fee patent year 16 | 31.08.2016 | Renewal fee patent year 17 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]EP0336298 (SQUIBB & SONS INC [US]); | [YD]EP0521471 (SHIONOGI & CO [JP]); | [YD]GB2262229 (SANDOZ LTD [CH]); | [Y]WO9416693 (WARNER LAMBERT CO [US]); | [Y]WO9723200 (KOWA CO [JP], et al); | by applicant | EP0521471 | GB2262229 | other | US5356896 | WO0035425 | WO0154688 | EP1223918 |